Shares of Integer Holdings Co. (NYSE:ITGR – Get Free Report) have received an average recommendation of “Moderate Buy” from the nine research firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $146.56.
A number of research firms have weighed in on ITGR. Piper Sandler reiterated an “overweight” rating and set a $140.00 price objective (up previously from $125.00) on shares of Integer in a research note on Friday, October 25th. Truist Financial boosted their price target on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Bank of America raised their price objective on shares of Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Tuesday, October 1st. KeyCorp boosted their target price on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday. Finally, Wells Fargo & Company restated an “overweight” rating and set a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd.
Read Our Latest Report on ITGR
Integer Stock Up 0.5 %
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Mather Group LLC. raised its holdings in shares of Integer by 304.3% during the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 143 shares during the last quarter. Contravisory Investment Management Inc. raised its stake in Integer by 55.9% in the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 80 shares during the last quarter. Huntington National Bank lifted its holdings in Integer by 8,933.3% in the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after purchasing an additional 268 shares in the last quarter. R Squared Ltd acquired a new stake in Integer during the 4th quarter worth $44,000. Finally, Versant Capital Management Inc grew its holdings in shares of Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after buying an additional 183 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.
About Integer
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Recommended Stories
- Five stocks we like better than Integer
- Short Selling – The Pros and Cons
- Sizing Up a New Opportunity for NVIDIA Investors
- Breakout Stocks: What They Are and How to Identify Them
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- What is an Earnings Surprise?
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.